Call for Abstract
World Conference on Epidemiology-Infectious Diseases and Public Health, will be organized around the theme “Challenges experienced and therapeutics adopted for diseases”
Epidemiology Conference 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Epidemiology Conference 2020
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Public Health Nursing is the practical approach of promoting and protecting the health of populations using knowledge from nursing, social, and public health sciences It also refers to the strength of open well-being. Open well-being medical caretakers are a community of medical caretakers who are included in joining a community and who knows well almost clinical strategies and treatment of well-being. Open well-being nursing is one of the ignored fields of the health sector. The nurses must be prepared to respond directly to public health crises; from outbreaks of disease to natural disasters. It is very important to provide the knowledge on emergingpublic health issues, to help nurses to make the most informed treatment decisions.
- Track 1-1Obesity & Public Health
- Track 1-2Oncology & Public Health
- Track 1-3Diabetes and Public Health
- Track 1-4Public Health & Nutrition
- Track 1-5Veterinary Public Health
- Track 1-6Occupational Health & Security
- Track 1-7Communal Health
Rare diseases affect small percentage of the population in recent years. Around 80% of rare diseases are genetic in origin. Cambridge Healthtech Institute’s symposium on Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are involved in finding new drug targets and drug modalities for treating rare disorders. This unique one-day event will encourage people from diverse backgrounds to discuss potential opportunities, as well as existing challenges in this field. It’s an opportunity for scientific and technical experts to come together to exchange ideas, experiences and to set up collaborations for rare disease research.
- Track 2-1Nanotechnology in drug delivery
- Track 2-2Immuno pharmacology
- Track 2-3Epidemiology and Antibiotic Resistance
- Track 2-4Homeopathy & Public Health
- Track 2-5Defensive Medication
Since 1990, maternal death worldwide has dropped by 45 percent, however consistently around 800 women die from preventable makes related pregnancy and labor. These deaths happen in low-pay settings subsequently of condition that includes hypertension, infection, high blood pressure, and complications during delivery. Maternal health is closely connected to infant survival. While great steps have been made in reducing global child mortality, newborns and now represent 44 percent of all child deaths. Every year, 2.9 million babies needlessly die within their first month and an extra 2.6 million are stillborn. The main cause, which are preventable and treatable, are confusions because of rashness, intricacies amid conveyance, and contamination. National organizations recognize the need to accelerate the development, delivery and impact at scale of new approaches to deal with need worldwide medical issues. These advancements will help in earlier diagnosis of pre-eclampsia and eclampsia, in distinguishing of abnormalities during labor, and in prevention of postpartum hemorrhage for women without access to skilled providers. Experts in child health and maternal focus on the complex public health problems affecting women, infants and their families. Their well-being determines the health of the next generation and can help future health care challenges for families, communities, and the public health care system.
- Track 3-1Reproductive, Perinatal and Pediatric Epidemiology
- Track 3-2Child and adolescent health
- Track 3-3Reproductive Medicine & Women’s Health
- Track 4-1Antibiotic Resistance & Diagnostics Pathology
- Track 4-2Ecological Epidemiology
- Track 4-3Epidemiology of Molecular Pathology
- Track 5-1Clinical Data Management
- Track 5-2Health systems and economics
- Track 5-3Healthcare & Hospital Management
- Track 6-1Epidemiology for Ophthalmology & Oral Health
- Track 6-2Digital & Dental healthcare
- Track 6-3Experimental Epidemiology
- Track 7-1Biomedical and Health Care Technologies
- Track 7-2Patient Safety & Quality Healthcare
A Nutraceutical could be a pharmaceutical-grade and standardized supplement. Within the US, "nutraceuticals" don't exist as an administrative category; they are directed as dietary supplements and nourishment added substances by the FDA beneath the specialist of the Government Nourishment, Sedate, and Corrective Act.
- Track 8-1Nutraceuticals in Diabetes and Blood Sugar Management
- Track 8-2Polyunsaturated Fatty acids as Nutraceuticals
- Track 8-3Mental Health and Nocosomal Infections
\r\n The branch of medicine which deals with the incidence, distribution, and possible control of diseases and other factors relating to health.
- Track 9-1Epidemiology and Respiratory Diseases
- Track 9-2Epidemiology and Nursing Care
- Track 9-3Psychiatric Epidemiology
- Track 9-4Epidemiology and Oral Health
- Track 9-5Social Epidemiology
- Track 9-6Clinical Epidemiology
- Track 9-7Cancer Epidemiology
Infectious diseases continue to have a major impact on the health of communities around the globe from the world HIV and tuberculosis (TB) epidemics, to the threat of resistant bacteria, to the challenge of emerging and newly identified pathogens. All compel the need for new ways to detect such pathogens, to understand their pathogenesis, and to devise effective interventions for their prevention and control. Infectious Disease Epidemiology collections of domestic and global works on the epidemiology of emerging and re-emerging infections, world infectious disease threats, disease surveillance, disease detection, vaccines development and other methods of prevention, various clinical trials, and the effect of infectious pathogens in the pathogenesis of chronic non-communicable diseases, like cancer and cardiovascular diseases.
- Track 10-1Sexual transmitted Infections (STI)
- Track 10-2Microbial & Infectious Disease Pathology
- Track 10-3Epidemiology and chronic diseases
- Track 11-1Healthcare & Hospital Organization
- Track 11-2Healthcare Associated illnesses
- Track 11-3Nursing and Health care
- Track 11-4Diabetes & its Complications
- Track 11-5Disease prevention, Control and elimination, Vaccine and Treatment
- Track 12-1Epidemiology and Genomic Research
- Track 12-2Cardiovascular Epidemiology
- Track 12-3Genetics and Multi System Diseases
The general practice is one of the medical practices, where the healthcare professional treats the incessant and intense sickness and gives preventive care and well-being instruction to the patients. And essential care is the well-being care given to the gather of individuals or community in some time recently drawing closer to the restorative specialist or the clinic. Essential care and general practice are the earlier measures taken some time recently begin the treatment.
- Track 13-1Personalized Medication
- Track 13-2Environment, Climate and Urban health
- Track 13-3Environmental Epidemiology
- Track 14-1Tropical Diseases in Animals
- Track 14-2Tropical Medicine and Various other Medicine
- Track 14-3Clinical Tropical Medicine
- Track 14-4Neglected Tropical Diseases
- Track 14-5Tropical Biomedical Sciences
Healthcare associated diseases are also called as Health care associated infections (HCAI). These are also referred as “hospital infection”, an infection occurring in the patient during the process of health care facility or in hospital. It can affect patients’ health in any type of settings where they patients were admitted or may also appear after the discharge
- Track 15-1Parasitology
- Track 15-2Pharmacoepidemiology and Clinical Research
- Track 15-3Renal Pharmacoepidemiology & Adrenergic drugs
- Track 15-4Forensic & Chemical Pathology